KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Novartis Ag (NVS) Other Gross PP&E Adjustments (2016 - 2025)

Novartis Ag's Other Gross PP&E Adjustments history spans 10 years, with the latest figure at $8.9 billion for Q2 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 13.29% to $8.9 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $8.9 billion, a 13.29% increase, with the full-year FY2024 number at -$27.0 million, down 1450.0% from a year prior.
  • Other Gross PP&E Adjustments hit $8.9 billion in Q2 2025 for Novartis Ag, up from -$27.0 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for NVS hit a ceiling of $10.0 billion in Q4 2021 and a floor of -$57.1 billion in Q2 2021.
  • Historically, Other Gross PP&E Adjustments has averaged -$4.5 billion across 5 years, with a median of $2.0 million in 2023.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 166500.0% in 2021 and later plummeted 13400.0% in 2023.
  • Tracing NVS's Other Gross PP&E Adjustments over 5 years: stood at $10.0 billion in 2021, then decreased by 6.52% to $9.3 billion in 2022, then crashed by 99.98% to $2.0 million in 2023, then crashed by 1450.0% to -$27.0 million in 2024, then skyrocketed by 33188.89% to $8.9 billion in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for NVS at $8.9 billion in Q2 2025, -$27.0 million in Q4 2024, and -$28.0 million in Q3 2024.